1CALL FOR PAPERS封22Heterogeneous populations of neural stem cells contribute to myelin repairRainer Akkermann, Felix Beyer, Patrick Küry509-5173Axon degeneration: make the Schwann cell great againKeit Men Wong, Bogdan Beirowski518-5244RhoA as a target to promote neuronal survival and axon regenerationJianli Hu525-5285The reasons for end-to-side coaptation: how does lateral axon sprouting work?Stefano Geuna, Igor Papalia, Giulia Ronchi, Francesco Stagno d'Alcontres, Konstantinos Natsis, Nikolaos A. Papadopulos, Michele R. Colonna529-5336Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseasesShiran Naftelberg, Gil Ast, Eran Perlson534-5377The complexities underlying age-related macular degeneration: could amyloid beta play an important role?Savannah A. Lynn, Eloise Keeling, Rosie Munday, Gagandeep Gabha, Helen Griffiths, Andrew J. Lotery, J. Arjuna Ratnayaka538-5488Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapyTuane Bazanella Sampaio, Anne Suely Savall, Maria Eduarda Ziani Gutierrez, Simone Pinton549-5579Endothelial progenitor cells as a therapeutic option in intracerebral hemorrhageJuan Pías-Peleteiro, Francisco Campos, José Castillo, Tomás Sobrino558-56110A tale of motor neurons and CD4+ T cells: moving forward by looking backAbhirami Kannan Iyer, Kathryn J. Jones562-56511Analyzing the role of extracellular matrix during nervous system development to advance new regenerative strategiesTeresa Caprile, Hernán Montecinos566-56712Nerves and hydrogen peroxide:how old enemies become new friendsFrancesca Meda, Alain Joliot, Sophie Vriz568-56913Ghosts in the shell: identification of microglia in the human central nervous system by P2Y12 receptorAlexander Mildner570-57114RhoA/ROCK activation in major pelvic ganglion mediates caspase-3 dependent nitrergic neuronal apoptosis following cavernous nerve injuryMichael Bell, Nikolai A. Sopko, Hotaka Matsui, Johanna L. Hannan, Trinity J. Bivalacqua572-57315Why and how does light therapy offer neuroprotection in Parkinson's disease?John Mitrofanis574-57516Delivery of therapeutics to posterior eye segment: cell-encapsulating systemsFrancisca S.Y. Wong, Ken K. Tsang576-57717Role of the STRIPAK complex and the Hippo pathway in synaptic terminal formationChisako Sakuma, Takahiro Chihara578-57918Regulatory role of microRNA on inflammatory responses of diabetic retinopathyEun-Ah Ye, Jena J. Steinle580-58119Food, polyphenols and neuroprotectionRui F.M. Silva, Lea Poga?nik582-58320Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degenerationMoeen Riaz, Paul N. Baird584-585 